FORA Capital’s Ionis Pharmaceuticals IONS Stock Holding History

FORA Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	13,833 -5,860	-30%	-$441K	0.08%	207
2026 Q1	$1.48M	Buy	+19,693	New	+$1.55M	0.11%	191
2025 Q2	–	Sell	-11,570	Closed	-$349K	–	599
2025 Q1	$349K	Buy	+11,570	New	+$379K	0.04%	383
2024 Q4	–	Sell	-5,081	Closed	-$204K	–	486
2024 Q3	$204K	Buy	+5,081	New	+$236K	0.02%	403
2022 Q2	–	Sell	-6,095	Closed	-$218K	–	552
2022 Q1	$218K	Buy	+6,095	New	+$199K	0.04%	468
2020 Q3	–	Sell	-4,838	Closed	-$285K	–	808
2020 Q2	$285K	Buy	+4,838	New	+$269K	0.1%	269

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

FORA Capital's IONS Position: Q2 2026 in Review

FORA Capital reduced its Ionis Pharmaceuticals (IONS) stake by 30% in Q2 2026, selling an estimated $441K and leaving 13,833 shares worth $1.1M. The position accounts for 0.08% of the portfolio, ranked #207.

FORA Capital first reported a position in IONS in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.48M in Q1 2026. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

FORA Capital held 13,833 shares of Ionis Pharmaceuticals worth $1.1M as of Q2 2026.
FORA Capital sold 5,860 Ionis Pharmaceuticals shares in Q2 2026, an estimated $441K.
Ionis Pharmaceuticals made up 0.08% of FORA Capital's portfolio in Q2 2026, its #207 holding.
FORA Capital first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
FORA Capital's Ionis Pharmaceuticals position peaked at $1.48M in Q1 2026.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.